>
Fa   |   Ar   |   En
   A Role for the Non-Receptor Tyrosine Kinase Abl2/Arg in Experimental Neuroinflammation  
   
نویسنده Jacobsen Freja Aksel ,Scherer Alexander N. ,Mouritsen Jeppe ,Bragadóttir Hera ,Bäckström B. Thomas ,Sardar Samra ,Holmberg Dan ,Koleske Anthony J. ,Andersson Åsa
منبع journal of neuroimmune pharmacology - 2018 - دوره : 13 - شماره : 2 - صفحه:265 -276
چکیده    Multiple sclerosis is a neuroinflammatory degenerative disease, caused by activated immune cells infiltrating the cns. the disease etiology involves both genetic and environmental factors. the mouse genetic locus, eae27, linked to disease development in the experimental autoimmune encephalomyelitis (eae) model for multiple sclerosis, was studied in order to identify contributing disease susceptibility factors and potential drug targets for multiple sclerosis. studies of an eae27 congenic mouse strain, revealed that genetic variation within eae27 influences eae development. the abl2 gene, encoding the non-receptor tyrosine kinase arg, is located in the 4,1 megabase pair long eae27 region. the arg protein plays an important role in cellular regulation and is, in addition, involved in signaling through the b- and t-cell receptors, important for the autoimmune response. the presence of a single nucleotide polymorphism causing an amino acid change in a near actin-interacting domain of arg, in addition to altered lymphocyte activation in the congenic mice upon immunization with myelin antigen, makes abl2/arg a candidate gene for eae. here we demonstrate that the non-synonymous snp does not change arg’s binding affinity for f-actin but suggest a role for abl kinases in cns inflammation pathogenesis by showing that pharmacological inhibition of abl kinases ameliorates eae, but not experimental arthritis.
کلیدواژه Abl kinase ,Arg ,Eae27 ,Experimental autoimmune encephalomyelitis ,Imatinib
آدرس University of Copenhagen, Department of Drug Design and Pharmacology, Denmark. Novo Nordisk A/S, Denmark, Yale University School of Medicine, Department of Cell Biology, USA, University of Copenhagen, Department of Drug Design and Pharmacology, Denmark. Novozymes A/S, Denmark, University of Copenhagen, Department of Drug Design and Pharmacology, Denmark. Xellia Pharmaceuticals A/S, Denmark, Novo Nordisk A/S, Denmark. BTB Pharma, Sweden, University of Copenhagen, Department of Drug Design and Pharmacology, Denmark, Lund University, Autoimmunity section, Sweden, Yale University School of Medicine, Department of Molecular Biophysics and Biochemistry, USA, University of Copenhagen, Department of Drug Design and Pharmacology, Denmark. University of Halmstad, Rydberg laboratories for Applied Science, Sweden
 
     
   
Authors
  
 
 

Copyright 2023
Islamic World Science Citation Center
All Rights Reserved